WhiteSwell Medical Overview
WhiteSwell Medical is a science-driven company dedicated to improving treatment of acute decompensated heart failure (ADHF), a primary cause of repeat hospitalization and emergency room visits. The company is developing a minimally invasive, catheter-based approach designed to more efficiently remove excess interstitial fluid in patients with ADHF by enhancing the natural fluid-removal process of the lymphatic system.
Cumulative Funding Raised Over Time ($)
$30.0MDec 2018
Latest News
WhiteSwell Adds Experienced Executives to its Senior Management Team
growth-positive
Catheter Stimulates Lymphatic Drainage for Heart Failure Treatment: Interview with Eamon Brady, CEO of WhiteSwell
WhiteSwell, a medtech company based in Galway, Ireland, has developed a catheter system to treat acute decompensated heart failure (ADHF). The technology stimulates lymphatic drainage to aid with decongestion without the need for diuretics. The company recently announced a US patent for the device and has conducted early feasibility studies in humans. ADHF affects millions of people globally and contributes to millions of hospitalizations each year. WhiteSwells technology has the potential to completely and rapidly decongest ADHF patients and protect kidney function. The company plans to continue clinical evaluation and move forward with extensive clinical trials.
Customers
WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart Failure With Newly Issued U.S. Patent
Growth-Positive
Europe Start-up 100: 25 medtech and life sciences start-ups to watch in 2019
The article lists 25 European medtech and life sciences start-ups to watch in 2019. These start-ups are pushing the innovation envelope further than ever thought possible. The start-ups listed are Ada, Aiforia, Ava, Bambi Medical, BioBeats, BrainWaveBank, Diaceutics, Dobco Medical Systems, Doctena, Etsimo, Fluidic Analytics, HealthBeacon, Heartbeat Medical, Healthera, Healx, Kite Medical, Medherant, Neurent Medical, Nuritas, Oura, Sword Health, UgenTec, Ultromics, WhiteSwell, and Xeltis.
CustomersInvestmentPartners
growth-positive
Israeli Medical Device Company WhiteSwell Raises $30 Million
WhiteSwell Ltd., a medical device company based in Ireland, has raised $30 million in a series B funding round led by RA Capital Management and InCube Ventures. The company plans to use the funding to develop its catheter-based technology for the treatment of acute decompensated heart failure (ADHF), a condition that causes severe fluid buildup in multiple organs. ADHF is responsible for nearly two million hospitalizations per year in the U.S. WhiteSwell is currently conducting an early feasibility study for the treatment at clinical sites in the U.S., Israel, and Europe.
Investment
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $30M |
| Last funding | $30M |
| Stage | B |
| Rounds | 1 |
| Investors | 2 |
Team Members
4
Employees: 11-50
Web & Social Links
| Website | whiteswell.com |
Locations
Shefayim, Israel
Galway, Ireland
2225 East Bayshore Road, Palo Alto, CA, USA
Photos & Videos
No files yet
WhiteSwell Medical Business
Business models
B2B
Product stage
R&D
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
—Tags (6)
cathetersminimally-invasivecardiovascularheart-failuremedical-devicesmedical-technologiesWhiteSwell Medical Financials
$30M
Total funding
Undisclosed
Capital raised
$30M
Last funding
B
Funding stage
1
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
$30.0MDec 2018
Private Equity Funding
B Round
Dec 2018
$30M
RA Capital Management, InCube Ventures
WhiteSwell Medical Lifecycle
Cumulative Funding Raised Over Time
$30.0MDec 2018
All Events
B Round
Dec 2018
$30M
RA Capital Management, InCube Ventures
WhiteSwell Medical News
5 articlesWhiteSwell Adds Experienced Executives to its Senior Management Team
growth-positive
Catheter Stimulates Lymphatic Drainage for Heart Failure Treatment: Interview with Eamon Brady, CEO of WhiteSwell
WhiteSwell, a medtech company based in Galway, Ireland, has developed a catheter system to treat acute decompensated heart failure (ADHF). The technology stimulates lymphatic drainage to aid with decongestion without the need for diuretics. The company recently announced a US patent for the device and has conducted early feasibility studies in humans. ADHF affects millions of people globally and contributes to millions of hospitalizations each year. WhiteSwells technology has the potential to completely and rapidly decongest ADHF patients and protect kidney function. The company plans to continue clinical evaluation and move forward with extensive clinical trials.
Customers
WhiteSwell Strengthens Patent Portfolio for Treatment of Acute Decompensated Heart Failure With Newly Issued U.S. Patent
Growth-Positive
Europe Start-up 100: 25 medtech and life sciences start-ups to watch in 2019
The article lists 25 European medtech and life sciences start-ups to watch in 2019. These start-ups are pushing the innovation envelope further than ever thought possible. The start-ups listed are Ada, Aiforia, Ava, Bambi Medical, BioBeats, BrainWaveBank, Diaceutics, Dobco Medical Systems, Doctena, Etsimo, Fluidic Analytics, HealthBeacon, Heartbeat Medical, Healthera, Healx, Kite Medical, Medherant, Neurent Medical, Nuritas, Oura, Sword Health, UgenTec, Ultromics, WhiteSwell, and Xeltis.
CustomersInvestmentPartners
growth-positive
Israeli Medical Device Company WhiteSwell Raises $30 Million
WhiteSwell Ltd., a medical device company based in Ireland, has raised $30 million in a series B funding round led by RA Capital Management and InCube Ventures. The company plans to use the funding to develop its catheter-based technology for the treatment of acute decompensated heart failure (ADHF), a condition that causes severe fluid buildup in multiple organs. ADHF is responsible for nearly two million hospitalizations per year in the U.S. WhiteSwell is currently conducting an early feasibility study for the treatment at clinical sites in the U.S., Israel, and Europe.
Investment
WhiteSwell Medical Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 38 |
| Team members | 5 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 6 classification IDs that could be used for matching.
WhiteSwell Medical Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | video or image, markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515130060 |
| Crunchbase | whiteswell |
| Phone | +97298331151 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-12-02T00:00:00.000Z |
| Created | 2018-12-11T00:00:00.000Z |